All News from PR Newswire

Thai Newswire x PR Newswire

ภาษาไทย | English
CISION PR Newswire - RYBREVANT® (amivantamab-vmjw) plus LAZCLUZE® (lazertinib) delivers statistically significant and clinically meaningful improvement in overall survival benefit for Asian patients with EGFR-mutated non-small cell lung cancer in the Phase 3 MARIPOSA study
PR Newswire

PR Newswire - RYBREVANT® (amivantamab-vmjw) plus LAZCLUZE® (laze...

SINGAPORE, Dec. 8, 2025 First and only chemotherapy-free combination in the first-line settin...

Read more
CISION PR Newswire - TenPay Global and Mastercard collaborate to enable fast and secure remittances to Weixin Pay
PR Newswire

PR Newswire - TenPay Global and Mastercard collaborate to enable...

SINGAPORE, Dec. 8, 2025 /PRNewswire/ -- TenPay Global, Tencent's cross-border payment platform, and ...

Read more
CISION PR Newswire - Dulwich College Ranjit Murugason Sustainability Fund Secures Renewed Support from LGT Bank Singapore to Advance Student-Led Initiatives
PR Newswire

PR Newswire - Dulwich College Ranjit Murugason Sustainability Fu...

SINGAPORE, Dec. 8, 2025 /PRNewswire/ -- The Dulwich College Ranjit Murugason Sustainability Fund is ...

Read more
CISION PR Newswire - Daesang Group's
PR Newswire

PR Newswire - Daesang Group's "Vietnam Scholarship Quiz Show" Ad...

Record participation as over 100,000 students nationwide compete in Vietnam's premier acade...

Read more
PR Newswire

PR Newswire - Global Times: Mogao Caves' mural paintings meet mo...

BEIJING, Dec. 8, 2025 /PRNewswire/ -- The flying Apsaras dance across the heavens; caravan bells ech...

Read more
CISION PR Newswire - CARsgen Announces Data of Allogeneic BCMA CAR-T Cell Therapy CT0596 for Relapsed/Refractory Multiple Myeloma at the 2025 ASH Annual Meeting
PR Newswire

PR Newswire - CARsgen Announces Data of Allogeneic BCMA CAR-T Ce...

SHANGHAI, Dec. 8, 2025 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 217...

Read more
CISION PR Newswire - AI-for-Science Startup ChemLex Raises USD 45M, Launching Self-Driving Lab for Drug Discovery in Singapore
PR Newswire

PR Newswire - AI-for-Science Startup ChemLex Raises USD 45M, Lau...

SINGAPORE, Dec. 8, 2025 /PRNewswire/ -- ChemLex, a next-generation AI-for-science company, today ann...

Read more
CISION PR Newswire - RESPIREE SECURES SINGAPORE HSA APPROVAL FOR ITS AI-ENABLED 1BIO™AI SOFTWARE TO SUPPORT ACUTE DETERIORATION DETECTION
PR Newswire

PR Newswire - RESPIREE SECURES SINGAPORE HSA APPROVAL FOR ITS AI...

SINGAPORE, Dec. 8, 2025 /PRNewswire/ -- AI/ML health-tech startup Respiree has received approval fro...

Read more
CISION PR Newswire - ProstACT Global Phase 3 Update: First Patient Dosed in Randomized Treatment Expansion, Part 1 Readout Plans Confirmed
PR Newswire

PR Newswire - ProstACT Global Phase 3 Update: First Patient Dose...

MELBOURNE, Australia and INDIANAPOLIS, Dec. 8, 2025 /PRNewswire/ -- Telix Pharmaceuticals Lim...

Read more
CISION PR Newswire - The 4th China International Supply Chain Expo Set for Beijing in June 2026
PR Newswire

PR Newswire - The 4th China International Supply Chain Expo Set ...

Sustained Worldwide Outreach Drives Greater Collaboration Opportunities BEIJING, Dec. 7, 2025...

Read more
CISION PR Newswire - CARsgen's CAR-T Product Zevor-Cel Included in China's Commercial Health Insurance Innovative Drug Catalogue
PR Newswire

PR Newswire - CARsgen's CAR-T Product Zevor-Cel Included in Chin...

SHANGHAI, Dec. 7, 2025 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 217...

Read more
CISION PR Newswire - All Approved Indications of Five Akeso's Innovative Drugs Included in China's Latest NRDL: Featuring Two First-in-Class Bispecifics with New First-Line Indications and Three Newly Negotiated Drugs
PR Newswire

PR Newswire - All Approved Indications of Five Akeso's Innovativ...

HONG KONG, Dec. 7, 2025 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") announced t...

Read more
Total : 27,234 Posts
1 ... 86 87 88 ... 2270
The information provided in this article was created by CISION PR Newswire, our news partner. The author's opinions and the content shared on this page are their own and may not necessarily represent the perspectives of Thai Newswire.